MENU
ATYR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
aTyr Pharma (ATYR) Ownership - Who owns aTyr Pharma?
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
138.71M
P/E Ratio
N/A
Total Cash
78.48M
Projected Growth
N/A
Total Debt
13.85M
Revenue
588K
Risk (Beta)
0.62
Dividend Yield
N/A
Total Cash/Share
1.04
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
ATYR
Capitalization
139M
P/E Ratio
N/A
Risk (Beta)
0.62
Dividend Yield
N/A
Total Cash
78.5M
Total Cash/Share
1.04
Total Debt
13.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
588K
ROE
N/A
Book Value
81.6M
P/B Ratio
1.70
Cash Flow
N/A
Earnings
-0.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
76K
Current Ratio
7.63
Current Revenue Per Employee
3983.05
Dividends Per Share - Security
N/A
EBITDA
-59.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.51
Shares Held By Institutions
139M
Shares Outstanding - Current
75.8M
Total Liabilities
24.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
29.787
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information